- ￥442 - 5960
- TargetMol
- T6066
- 2026年07月07日
2 年钻石会员
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- CAS号：
942183-80-4
- 规格：
1mg/1mLx10mM(inDMSO)/2mg/5mg/10mg/25mg/50mg/100mg/200mg
| 规格： | 1mg | 产品价格： | ￥442.0 |
|---|---|---|---|
| 规格： | 1mLx10mM(inDMSO) | 产品价格： | ￥1128.0 |
| 规格： | 2mg | 产品价格： | ￥644.0 |
| 规格： | 5mg | 产品价格： | ￥872.0 |
| 规格： | 10mg | 产品价格： | ￥1264.0 |
| 规格： | 25mg | 产品价格： | ￥2184.0 |
| 规格： | 50mg | 产品价格： | ￥3168.0 |
| 规格： | 100mg | 产品价格： | ￥4504.0 |
| 规格： | 200mg | 产品价格： | ￥5960.0 |
Product Introduction
Bioactivity
| 名称 | SCH772984 |
| 描述 | SCH772984 is an ERK inhibitor that inhibits ERK1 and ERK2 (IC50=4/1 nM) and is highly selective and ATP-competitive. SCH772984 exhibits antitumor activity against BRAF or RAS mutant cells. |
| 细胞实验 | For resistant cell line creation, cells were grown in Dulbecco's modified Eagle medium with 10% heat-inactivated FBS media and increasing concentrations of inhibitor (PLX4032, 0.1–10 μmol/L; GSK1120212, 0.01–1 μmol/L) over approximately 4 to 8 months until resistant cells acquired growth properties similar to na?ve parental cells (at their top drug concentrations). For combination resistance, cells were incubated as above but with alternative dose escalation until a top concentration was acquired (PLX4032 10 μmol/L and GSK1120212 1 μmol/L). Stocks and dilutions of PLX4032, GSK1120212, and SCH772984 were made in DMSO solvent. Cell proliferation experiments were carried out in a 96-well format (six replicates), and cells were plated at a density of 4,000 cells per well. At 24 hours after cell seeding, cells were treated with DMSO or a 9-point IC50 dilution (0.001–10 μmol/L) at a final concentration of 1% DMSO for all concentrations. Viability was assayed 5 days after dosing using the ViaLight luminescence kit following the manufacturer's recommendations (n = 6, mean ± SE). For the cell line panel viability assay, cells were treated with SCH772984 for 4 days and assayed by the CellTiterGlo luminescent cell viability assay. For IncuCyte analysis, cells were plated as above in 96-well plates, and image-based cell confluence data were collected every 2 hours during live growth. For engineered resistant lines, cells were infected with lentivirus produced from lentiORF constructs expressing either RFP, KRASG13D, BRAFV600E, truncated BRAFV600E lacking exons 2–8 (Δ2-8), MEK1P124L, MEK1F129L, or constitutively active MEK1DD (S218D+S222D). Cells were selected in blasticidin (20 μg/mL) and used for ViaLight assays as described above [1]. |
| 激酶实验 | SCH772984 was tested in 8-point dilution curves in duplicate against purified ERK1 or ERK2. The enzyme was added to the reaction plate and incubated with the compound before adding a solution of substrate peptide and ATP. Fourteen microliters of diluted enzyme (0.3 ng active ERK2 per reaction) was added to each well of a 384-well plate. The plates were gently shaken to mix the reagents and incubated for 45 minutes at room temperature. The reaction was stopped with 60 μL of IMAP Binding Solution (1:2,200 dilutions of IMAP beads in 1× binding buffer). The plates were incubated at room temperature for an additional 0.5 hours to allow complete binding of phosphopeptides to the IMAP beads. Plates were read on the LJL Analyst [1]. |
| 动物实验 | Nude mice were injected subcutaneously with specific cell lines, grown to approximately 100 mm^3, randomized to treatment groups (10 mice/group), and treated intraperitoneally with either SCH772984 or vehicle according to the dosing schedule indicated in the figure legends. Tumor length (L), width (W), and height (H) were measured during and after the treatment periods by a caliper twice weekly on each mouse and then used to calculate tumor volume using the formula (L × W × H)/2. Animal body weights were measured on the same days twice weekly. Data were expressed as mean ± SEM. Upon completion of the experiment, vehicle- and SCH772984-treated tumor biopsies were processed for Western blot analysis [1]. |
| 体外活性 | 方法: 21 种含有BRAF基因突变的黑色素瘤细胞系用 SCH772984 (0-10 µM) 处理 72-120 h，使用 CellTiter-Glo Luminescent Cell Viability Assay 检测细胞活力。 结果: 在 21 种细胞系中，对 SCH-772984 的敏感性分为3组：高敏感性 (IC50< 1 µM)、中敏感性 (IC50= 1-2 µM) 和耐药性 (IC50> 2 µM)。[1] 方法: BRAF 突变体 A375 细胞用 SCH772984 (0.1-2 µmol/L) 处理 4 h，使用 Western Blot 检测靶点蛋白表达水平。 结果: Epirubicin 在 G2/M 阻滞中显著增加了 sub-G 细胞。[2] |
| 体内活性 | 方法: 为检测体内抗肿瘤活性，将 SCH772984 (25-50 mg/kg) 腹腔注射给携带 MiaPaCa 异种移植物的 Nude 小鼠，每天两次，持续十四天。 结果: 在两种剂量下均观察到肿瘤消退，25 mg/kg 剂量下肿瘤消退 9%，50 mg/kg 剂量下肿瘤消退 36%。[2] |
| 存储条件 | Store at low temperature Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | H2O : < 1 mg/mL (insoluble or slightly soluble) Ethanol : < 1 mg/mL (insoluble or slightly soluble) 10% DMSO+90% Saline : 0.54 mg/mL (0.92 mM), Solution. DMSO : 16.7 mg/mL (28.42 mM), Sonication is recommended. |
| 关键字 | SCH-772984 | SCH772984 | SCH 772984 | Inhibitor | inhibit | Extracellular signal regulated kinases | ERK2 | ERK1 | ERK |
| 相关产品 | Urea | 4-Methylbenzylidene camphor | Astragaloside IV | Lactose | Tauroursodeoxycholate | Gum arabic | β-Glycerophosphate disodium salt hydrate | Gluconate Calcium | Propoxur | β-Glycerophosphate disodium salt pentahydrate | TBHQ | L-Cysteine |
| 相关库 | Inhibitor Library | Bioactive Compound Library | Anti-Cancer Active Compound Library | Bioactive Compounds Library Max | Kinase Inhibitor Library | Neural Regeneration Compound Library | Anti-Aging Compound Library | Highly Selective Inhibitor Library | HIF-1 Signaling Pathway Compound Library | Cancer Cell Differentiation Compound Library | Immunology/Inflammation Compound Library | Pain-Related Compound Library |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
官网有文献
相关实验
网络 第十九章 杂环化合物和生物碱 杂环化合物在自然界分布很广，其数量几乎占已知有机化合物的三分之一，用途也很多。许多重要的物质如叶绿素、血红素、核酸以及临床应用的一些有显著疗效的天然药物和合成药物等，都含有杂环化合物的结构。生物碱多是中草药的有效成分，绝大多数是含氮的杂环化合物。本章内容与医学关系密切，具有重要意义。
分子中具有高能键的化合物。在生物体内主要有上式（Ⅰ）和（Ⅱ）两种结构的高能化合物。其作用为贮藏能量（例如 ATP、肌酸磷酸）和作为产生 ATP源的中间代谢产物（例如磷酸烯醇丙酮酸）以及合成反应的中间物质（例如酰基辅酶 A），在蛋白质的结构（ conformation）变化周期的第一阶段上（例如钠钾 ATP酶的羧基磷酸中间体）也具有重要作用。多数高等化合物具有磷酸基，但也有例外。
由不同种元素组成的纯净物叫做化合物。化合物一般有固定的组成。化合物的组成一般可用化学式表示。化合物具有确定的物理性质和化学性质，不同于其组成元素的性质。化合物中的元素不能用简单的机械方法或物理方法分开，而必须用化学方法才能分离。
技术资料暂无技术资料 索取技术资料
文献支持
化合物 SCH772984【942183-80-4】
￥442 - 5960
